Montgom.. (DB RCT)0%1.00 · 0.32–3.07death6/4526/451TACKLE Montgom.. (DB RCT)50%0.50 · 0.13–1.98death3/4526/451TACKLE Montgom.. (DB RCT)50%0.50 · 0.29–0.86severe case18/40737/415TACKLE Montgom.. (DB RCT)57%0.43 · 0.25–0.75hosp.17/41340/421TACKLE Lombardi−368%4.68 · 0.31–71.62death1/191/89Immunocompromised OT¹ Lombardi33%0.67 · 0.09–5.13hosp.1/197/89Immunocompromised OT¹ Lombardi−24%1.24 · 0.90–1.70viral+14/1953/89Immunocompromised OT¹ Holland (DB RCT)23%0.77 · 0.57–1.03death80/710101/707ACTIV-3/TICO Holland (DB RCT)30%0.70 · 0.50–0.97death61/71086/707ACTIV-3/TICO Holland (DB RCT)3%0.97 · 0.80–1.17death/hosp.212/710213/707ACTIV-3/TICO Holland (DB RCT)7%0.93 · 0.83–1.03no recov.710 (n)707 (n)ACTIV-3/TICO Hites (DB RCT)40%0.60 · 0.28–1.23death12/12316/103DisCoVeRy Hites (DB RCT)−18%1.18 · 0.73–1.927-point status123 (n)103 (n)DisCoVeRy Hites (DB RCT)1%0.99 · 0.75–1.30recov. time123 (n)103 (n)DisCoVeRy Hites (DB RCT)9%0.91 · 0.70–1.19no disch.123 (n)103 (n)DisCoVeRy Chua (PSM)−50%1.50 · 0.28–8.04ventilation2/834/249 Chua (PSM)8%0.92 · 0.31–2.75ICU4/8313/249 Chua (PSM)33%0.67 · 0.39–1.16oxygen13/8358/249 Levin (DB RCT)42%0.58 · 0.34–1.00symp. case27/74923/372STORM CHASER Levin (DB RCT)33%0.67 · 0.36–1.24symp. case23/74917/372STORM CHASER Levin (DB RCT)86%0.14 · 0.01–2.98death0/3,4412/1,731PROVENT Levin (DB RCT)82%0.18 · 0.09–0.35symp. case11/3,44131/1,731PROVENT Levin (DB RCT)76%0.24 · 0.10–0.55symp. case8/3,44117/1,731PROVENT Young-Xu (PSM)64%0.36 · 0.18–0.73death1,733 (n)6,354 (n)Immunocompromised Young-Xu (PSM)69%0.31 · 0.18–0.53cases/death/hosp.17/1,733206/6,354Immunocompromised Young-Xu (PSM)87%0.13 · 0.02–0.99hosp.1,733 (n)6,354 (n)Immunocompromised Young-Xu (PSM)66%0.34 · 0.13–0.87cases1,733 (n)6,354 (n)Immunocompromised Ollila76%0.24 · 0.01–5.61death0/251/12Immunocompromised Ollila90%0.10 · 0.01–1.75cases0/253/12Immunocompromised Kertes92%0.08 · 0.01–0.54death/hosp.1/82563/4,299Immunocompromised Kertes47%0.53 · 0.32–0.85cases29/825308/4,299Immunocompromised Najjar-Debbiny59%0.41 · 0.19–0.89hosp.72/703377/2,812Immunocompromised Najjar-Debbiny25%0.75 · 0.58–0.96cases72/703377/2,812Immunocompromised Kaminski92%0.08 · 0.01–1.16death1/3332/97Immunocompromised Kaminski96%0.04 · 0.01–0.24ICU2/3336/97Immunocompromised Kaminski95%0.05 · 0.01–0.16hosp.4/33311/97Immunocompromised Kaminski99%0.01 · 0.06–0.20symp. case41/33342/97Immunocompromised Al Jurdi86%0.14 · 0.01–2.75death0/2223/222Immunocompromised Al Jurdi83%0.17 · 0.02–1.37hosp.1/2226/222Immunocompromised Al Jurdi66%0.34 · 0.18–0.66cases11/22232/222Immunocompromised Sindu (PSM)−1%1.01 · 0.14–7.21death2/172/17Immunocompromised Sindu (PSM)−96%1.96 · 0.18–21.60ventilationn/an/aImmunocompromised Sindu (PSM)−210%3.10 · 0.32–29.77ICUn/an/aImmunocompromised Sindu (PSM)53%0.47 · 0.16–1.40hosp.n/an/aImmunocompromised Sindu29%0.71 · 0.46–1.11symp. case24/20357/343Immunocompromised Din19%0.81 · 0.32–2.04hosp.5/2311/41Immunocompromised Desai12%0.88 · 0.33–2.35hosp.391 (n)391 (n) Desai−35%1.35 · 0.87–2.10cases391 (n)391 (n) Solera26%0.74 · 0.32–1.60severe case7/156283/1,819 Bes-Berlandier−10%1.10 · 0.37–3.31progression3/1415/77 Dluzynski−70%1.70 · 0.93–3.12cases70/47111/126Immunocompromised Haidar (DB RCT)−104%2.04 · 0.84–4.95death24/1,1026/561SUPERNOVA